Articles from BioConsortia, Inc.

BioConsortia, Inc., a leader in microbial innovation for sustainable agriculture, announced today it has secured $15 million in funding from its long-standing internal investors, led by Otter Capital and affiliated funds.

BioConsortia, Inc., a leader in agricultural technology specializing in advanced microbial solutions to enhance crop productivity and reduce agriculture’s ecological impact, has announced a commercial agreement with New Zealand-based H&T (Hodder and Taylors Ltd). H&T, known for improving crop and forage systems on New Zealand farms, will introduce BioConsortia's FixiN 33 microbial seed treatment during the 2024/2025 season. This innovative seed coating will be available for corn, brassicas, and cereals, helping growers optimize nitrogen fertilizer use while reducing runoff and environmental impact.

BioConsortia’s new biofungicide/bactericide, AmaraTM has received registration from the Environmental Protection Agency (EPA). With potential applications in high-value fruit and vegetable production, the product is designed to protect crops from foliar diseases with a biological mode of action that offers an alternative to chemical fungicides and with a greater consistency in efficacy than current biological products on the market.

BioConsortia, Inc., a leading agricultural technology company that discovers, designs and out licenses advanced microbial products to reduce the ecological impacts of agriculture while ensuring crop productivity, this week unveiled the latest results of SOLVARIX bionematicide field testing during an industry meeting in Campinas, Brazil. The company also shared latest yield findings from Brazilian trials of ALWAYS-N seed treatments and conducted meetings with commercial partners.

BioConsortia, Inc., a leading agricultural technology company that discovers, designs and licenses advanced microbial products to reduce the ecological impacts of agriculture while ensuring crop productivity, today announced that the Company has closed an internal financing round that will fund expanded development of microbial products designed to increase crop yields by fixing nitrogen or controlling nematode, fungal and soil insect pests. Existing investor Otter Capital led the round, excited by progress shown in recent field trial results, as well as new discoveries that further enhance BioConsortia’s microbial gene-editing leadership position.

BioConsortia, Inc., a leading agricultural technology company that discovers, designs and licenses advanced microbial products to reduce the ecological impacts of agriculture while ensuring crop productivity, today announced that the Company has further developed its nitrogen-fixing products in row crops, demonstrating through hundreds of field trials conducted in 2023 that the products effectively displace meaningful levels of nitrogen fertilizer and deliver yield gains.

BioConsortia, Inc., a leading agricultural technology company that designs and licenses advanced microbial products to reduce the ecological impacts of agriculture while ensuring crop productivity, today announced that the Company has developed nitrogen-fixing products to expand the addressable market to new crop opportunities.

BioConsortia, Inc., a leader in R&D for sustainable agriculture with a mission to unleash the power of microbes to meet the world’s food needs while reducing agriculture’s ecological impact, today announced its strategic expansion into Brazil. With a focus on next-generation microbial products that reduce the need for synthetic nitrogen fertilizer and protect crops from yield-robbing pests like diseases, nematodes and soil insects, BioConsortia is at the forefront of the regenerative agriculture revolution.

BioConsortia, Inc. today announces implementation of its largest proprietary field trials program to date, with hundreds of tests planned or already underway for the 2023 field season. These field trials are the final development stage of the company’s new products for nitrogen fixation, nematode control, disease control and plant biostimulation.

BioConsortia, Inc., a leader in R&D for sustainable agriculture, whose mission is to unleash the power of microbes to meet the world’s food needs while reducing agriculture’s ecological impact, today announced company leaders will highlight their team’s innovative nitrogen-fixing microbial products. SVP Business Development Sarah Reiter will participate in New Ag International’s Annual Conference on Cutting Edge Innovation in Fertilizers and Plant Nutrition in Barcelona on April 18 and 19. BioConsortia’s CEO, Marcus Meadows-Smith, will participate in the BioAg World Congress in Rio de Janeiro May 2 through 5.

BioConsortia, Inc., a leader in R&D for sustainable agriculture, whose mission is to unleash the power of microbes to meet the world’s food needs while reducing agriculture’s ecological impact, today announced CEO Marcus Meadows-Smith will present at the Bank of America Securities 2023 Global Agriculture and Materials Conference in Fort Lauderdale on March 1 and 2. A panel featuring BioConsortia’s CEO will discuss the use of “Biologics in Crop Production” on Thursday, March 2 at 9:30AM.

BioConsortia, Inc., a recognized leader in the field of gene-editing to unleash the power of microbes for crop protection, nitrogen-fixation and yield improvement, announced today that Dr. Damian Curtis, BioConsortia’s Director of Synthetic Biology and Genomics, will present “Unleashing the Power of Microbes to Meet the World’s Food Needs” at the 5th Annual CRISPR AgBio Congress. The event will take place in San Diego, February 14 to 16, 2023.

BioConsortia Inc. announced today its 2022 field trial results for the company’s nematicide seed treatment products. This advances two new nematicides leads into the development pipeline, bringing the number of products in mid- to late-stage development as nematicides applied as seed treatments to five. The data demonstrate BioConsortia’s R&D platform consistently delivers a robust group of microbial product leads that increase yields in a variety of crops including vegetables, wheat, corn and soybeans.

BioConsortia, Inc. today announced the company has been nominated as a finalist for the 2022 S&P Global Commodity Insights’ Crop Science Awards in the category of Best R&D Pipeline. The highly coveted awards, formerly known as the Agrow Awards, draw submissions from around the world highlighting the creativity and innovation permeating the industry. The nomination coincides with results from 2022 trials conducted in 20 states confirming superior product performance in the field.

BioConsortia, Inc. and The Mosaic Company (NYSE: MOS) have entered into a new agreement to distribute BioConsortia’s new microbial biostimulant in Asia.

BioConsortia today announced the addition of Sarah Reiter to lead Business Development, as the company moves towards registration and product launch for multiple products.

BioConsortia, Inc. has moved two new nematicides into its development and registration phase following excellent field trial results in corn and other important food crops. The new products control nematode pests and increase crop yields.

As BioConsortia continues its discovery and development of powerful microbes with unique modes of action and innovates further into gene editing for microbial biopesticides and nitrogen fixation, we are pleased to announce that Nancy Vosnidou will join the BioConsortia team in the newly created position of IP & Portfolio Strategist.